Literature DB >> 27539773

Frequency and Outcome of Meningitis in Pediatric Intensive Care Unit of Pakistan.

Amna Jawaid1, Surriya Bano1, Anwar Ul Haque2, Khubaib Arif1.   

Abstract

Meningitis is a leading cause of morbidity and mortality worldwide in intensive care settings. The aim of this study was to assess the frequency and outcome in children with meningitis through a retrospective chart review done in pediatric intensive care unit of a tertiary care hospital from January 2000 to December 2014. During these 14 years, 64 patients were admitted with meningitis in pediatric intensive care unit. Out of 64, 36 were diagnosed with pyogenic meningitis, 18 patients with viral meningitis, and 10 with tuberculous meningitis. Most complications were observed in the initial 48 hours. Most common presentation was altered level of consciouness in 50 (78.1%), seizure in 38 (59.4%), and shock in 23 (35.9%) patients. Ventilatory support was required in 30 (46.9%) patients and inotropic support in 26 (40.6%). During stay in pediatric intensive care unit, there was 7.8% mortality. Although meningitis was an infrequent cause of hospitalization at the study centre, but it was an important infectious cause of mortality and morbidity in pediatric age group and associated with high neurological sequelae.

Entities:  

Mesh:

Year:  2016        PMID: 27539773     DOI: 2415

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  2 in total

Review 1.  Etiology, Clinical Phenotypes, Epidemiological Correlates, Laboratory Biomarkers and Diagnostic Challenges of Pediatric Viral Meningitis: Descriptive Review.

Authors:  Saleh M Al-Qahtani; Ayed A Shati; Youssef A Alqahtani; Abdelwahid Saeed Ali
Journal:  Front Pediatr       Date:  2022-06-16       Impact factor: 3.569

2.  Hearing impairment after acute bacterial meningitis in children.

Authors:  Fatima Zeeshan; Attia Bari; Mubeen Nazar Dugal; Fauzia Saeed
Journal:  Pak J Med Sci       Date:  2018 May-Jun       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.